General Mills, Inc.
Featured
Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates
Dogwood Therapeutics posts Q4 loss of $0.26/share, 69.8% narrower than the $0.86 consensus, as clinical-stage biotech reduces burn rate.
3 hours ago
General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B
General Mills Q3 EPS of $0.64 missed estimates by 12.1% as strategic pricing investments weighed on results; management reaffirms guidance, expects Q4 improvement.